Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04176575 · ClinicalTrials.gov registry record · NA

Balancing Method for Pain Related to Advanced Cancer

A NA study of Metastatic Cancer and Pain, Cancer, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT04176575: Completed NA study of Metastatic Cancer and Pain, Cancer, sponsored by University of Pittsburgh.

NCT04176575 is a NA study of Metastatic Cancer and Pain, Cancer that has completed, run by University of Pittsburgh. The registered enrollment target is 6 participants, below the 444-participant average among 109 other Metastatic Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04176575, a NA study of Metastatic Cancer and Pain, Cancer, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

Balancing Method for Pain Related to Advanced Cancer seeks to confirm the benefit of acupuncture for patients with pain related to advanced cancer.

Primary Outcome

Participant report of pain on average on a scale from 'no pain' (0) to "worst imaginable pain" (10). Higher scores mean worse outcome.

Interventions

  • OTHER Acupuncture

Study Locations (1)

Pennsylvania

  • UPMC Center for Integrative Medicine - Pittsburgh

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2022-07-05
Est. Completion 2024-01-20
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT04176575 record still lists

NCT04176575 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 444-participant average among 109 other Metastatic Cancer trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Metastatic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Acupuncture is the first listed.

NCT04176575 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04176575 about?

NCT04176575 is a clinical study titled "Balancing Method for Pain Related to Advanced Cancer". Balancing Method for Pain Related to Advanced Cancer seeks to confirm the benefit of acupuncture for patients with pain related to advanced cancer.

What is the current status of trial NCT04176575?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2022-07-05. Estimated completion is 2024-01-20.

What conditions does trial NCT04176575 study?

This clinical trial studies the following conditions: Metastatic Cancer, Pain, Cancer, Invasive Cancer.

What interventions are being tested in trial NCT04176575?

The interventions under investigation include: Acupuncture (OTHER).

Who is sponsoring clinical trial NCT04176575?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04176575 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metastatic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04176575's enrollment target sits among peer trials

6 107th of 109 higher than 2 of 109 other Metastatic Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Metastatic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04176575, the US trial registry maintained by the National Library of Medicine. NCT04176575 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.